Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study

BACKGROUND: The efficacy and safety of upadacitinib in atopic dermatitis (AD) have been defined in clinical trials, but no real-world data are currently available. We aimed to assess the safety and effectiveness of upadacitinib in a real-world AD patient cohort that mostly included patients who fail...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiricozzi, Andrea, Gori, Niccolò, Narcisi, Alessandra, Balato, Anna, Gambardella, Alessio, Ortoncelli, Michela, Marzano, Angelo Valerio, Balestri, Riccardo, Palazzo, Giovanni, Pellegrino, Michele, Romanelli, Marco, Tripepi, Giovanni, Peris, Ketty, Costanzo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362214/
https://www.ncbi.nlm.nih.gov/pubmed/35922713
http://dx.doi.org/10.1007/s40268-022-00396-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362214/
https://www.ncbi.nlm.nih.gov/pubmed/35922713
http://dx.doi.org/10.1007/s40268-022-00396-1

Ejemplares similares